12/06/2024
3:34 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:35 PM | Aileron Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:38 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:41 PM | Aileron Therapeutics (Issuer)
Aivado Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:03 PM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
4:17 PM | Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
| Form SCHEDULE 13G/A | |
08/22/2024
3:05 PM | Aileron Therapeutics (Issuer)
Musso Alan A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/22/2024
3:06 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:06 PM | Aileron Therapeutics (Issuer)
Fairey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:07 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:09 PM | Aileron Therapeutics (Issuer)
Aivado Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
4:12 PM | Aileron Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
4:23 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:29 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
07/26/2024
3:33 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
07/26/2024
3:36 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
7:41 AM | Aileron Therapeutics (Filer)
| Form ARS | |
07/09/2024
7:30 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
07/09/2024
7:36 AM | Aileron Therapeutics (Filer)
| Form DEFA14A | |
06/17/2024
6:03 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
5:18 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:59 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
5:58 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:19 PM | Aileron Therapeutics (Issuer)
Cunningham Timothy M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/15/2024
4:16 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
4:54 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4/A | |
05/01/2024
6:15 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
4:24 PM | Aileron Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
4:25 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
4:16 PM | Aileron Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:40 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:54 AM | Aileron Therapeutics (Subject)
| Form FWP | |
04/30/2024
2:32 PM | Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2024
7:33 AM | Aileron Therapeutics (Filer)
| Form 10-K/A | |
04/16/2024
4:16 PM | Aileron Therapeutics (Subject)
Satter Muneer A (Filed by)
| Form SC 13D/A | |
04/15/2024
4:21 PM | Aileron Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
4:22 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:15 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4/A | |
04/10/2024
3:15 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4/A | |
04/02/2024
5:10 PM | Aileron Therapeutics (Issuer)
Garner Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
3:15 PM | Aileron Therapeutics (Filer)
| Form NT 10-K | |
Genesis leading the smart algo revolution? (Ad) I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before…
Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from.
Here’s why:
It does all the heavy lifting for you… automatically.
Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart! You’ll want to see what I’ve put on this page right here |
03/29/2024
7:03 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:06 PM | Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:14 PM | Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
| Form SC 13G | |
03/01/2024
3:05 PM | Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:05 PM | Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
9:28 AM | Aileron Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
6:01 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
11:15 PM | Aileron Therapeutics (Filer)
| Form EFFECT | |
02/05/2024
12:20 PM | Aileron Therapeutics (Subject)
Kapnick Scott (Filed by)
| Form SC 13G/A | |
01/29/2024
7:46 AM | Aileron Therapeutics (Filer)
| Form DEF 14A | |
01/29/2024
7:48 AM | Aileron Therapeutics (Filer)
| Form ARS | |
01/29/2024
7:14 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
6:00 AM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:44 PM | Aileron Therapeutics (Filer)
| Form PRE 14A | |
01/11/2024
3:18 PM | Aileron Therapeutics (Filer)
| Form 8-K/A | |
01/10/2024
3:08 PM | Aileron Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ALRN Stock Alerts